Bispecific GLP-1/GLP-2 agonism in advanced type 2 diabetes: preclinical characterization and a randomized, double-blind, placebo-controlled phase I trial

Journal:
Nature Communications
Published:
DOI:
10.1038/s41467-026-71080-0
Affiliations:
3
Authors:
7
Go to article
Institutions Authors Share
ProGen Inc., South Korea
5.000000
 0.71
SL BIGEN. Co., Ltd., South Korea
1.500000
 0.21
Pohang University of Science and Technology (POSTECH), South Korea
0.500000
 0.07
Interested in Pharmacology and Pharmaceutical Sciences?